Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Hernández Sánchez JM"'
Autor:
Caballero JC, Sánchez Barba M, Hernández Sánchez JM, Such E, Janusz K, Sanz G, Cabrero M, Chillón C, Cervera J, Hurtado AM, Jerez A, Calderón Cabrera C, Valcárcel D, Lumbreras E, Abáigar M, López Cadenas F, Hernández Rivas JM, Del Cañizo MC, Díez Campelo M
Publikováno v:
ANNALS OF HEMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Somatic mutations in patients with myelodysplastic syndromes (MDS) undergoing allogeneic hematopoietic stem cell transplantation (HSTC) are associated with adverse outcome, but the role of chronic graft-versus-host disease (cGVHD) in this subset of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::015a5ae7668728b22adad78b2800b4d0
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10361
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10361
Autor:
González MDR; Institute for Biomedical Research of Salamanca (IBSAL), Institute of Cancer Molecular and Cellular Biology (IBMCC)-Centro de Investigación del Cáncer, Universidad de Salamanca, Salamanca, Spain.; Department of Pathology, New York University Grossman School of Medicine, New York, NY, United States., Chakraborty S; Department of Pathology, New York University Grossman School of Medicine, New York, NY, United States., Hernández-Sánchez JM; Institute for Biomedical Research of Salamanca (IBSAL), Institute of Cancer Molecular and Cellular Biology (IBMCC)-Centro de Investigación del Cáncer, Universidad de Salamanca, Salamanca, Spain., Diez Campelo M; Hematology Department, Hospital Universitario Salamanca, Salamanca, Spain., Park CY; Department of Pathology, New York University Grossman School of Medicine, New York, NY, United States., Hernández Rivas JM; Institute for Biomedical Research of Salamanca (IBSAL), Institute of Cancer Molecular and Cellular Biology (IBMCC)-Centro de Investigación del Cáncer, Universidad de Salamanca, Salamanca, Spain.; Hematology Department, Hospital Universitario Salamanca, Salamanca, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Sep 23; Vol. 14, pp. 1438052. Date of Electronic Publication: 2024 Sep 23 (Print Publication: 2024).
Autor:
Caballero JC; Hematology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Dávila J; Hematology Department, Hospital Nuestra Señora de Sonsoles, Ávila, Spain., López-Pavía M; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Universidad de Valencia, Valencia, Spain., Such E; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Universidad de Valencia, Valencia, Spain., Bernal T; Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Ramos F; Hematology Department, Hospital Universitario de León, León, Spain., Calabuig M; Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain., Hernández Sánchez JM; Instituto de Biología Molecular y Celular del Cáncer, Instituto Biosanitario de Salamanca, Centro de Investigación del Cáncer, USAL-CSIC, Salamanca, Spain., Pomares H; Hematology Department, Hospital Universitario de Bellvitge-Hospital Duran I Reynals, Instituto Catalán de Oncología, L'Hospitalet del Llobregat, Spain., Sánchez Barba M; Statistics Department, Universidad de Salamanca, Salamanca, Spain., Abáigar M; Instituto de Biología Molecular y Celular del Cáncer, Instituto Biosanitario de Salamanca, Centro de Investigación del Cáncer, USAL-CSIC, Salamanca, Spain., González B; Hematology Department, Hospital Universitario de Canarias, La Laguna, Spain., Merchán B; Hematology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Sancho-Tello R; Hematology Department, Hospital Arnau de Vilanova, Valencia, Spain., Callejas M; Hematology Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain., Muñoz-Novas C; Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain., Cerveró C; Hematology Department, Hospital Virgen de la Luz, Cuenca, Spain., Sanz G; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Universidad de Valencia, Valencia, Spain., Hernández Rivas JM; Instituto de Biología Molecular y Celular del Cáncer, Instituto Biosanitario de Salamanca, Centro de Investigación del Cáncer, USAL-CSIC, Salamanca, Spain Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain Instituto Biosanitario de Salamanca, Salamanca, Spain.; Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain Instituto Biosanitario de Salamanca, Salamanca, Spain.; Instituto Biosanitario de Salamanca, Salamanca, Spain., Díez Campelo M; Hematology Department, Hospital Universitario de Salamanca, Paseo de San Vicente 58-182, Salamanca 37007, Spain.; Instituto Biosanitario de Salamanca, Salamanca, Spain.
Publikováno v:
Therapeutic advances in hematology [Ther Adv Hematol] 2024 Jan 04; Vol. 15, pp. 20406207231218157. Date of Electronic Publication: 2024 Jan 04 (Print Publication: 2024).
Autor:
Quwaider D; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Hematology Department, University Hospital of Salamanca, Salamanca, Spain., Corchete LA; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Hematology Department, University Hospital of Salamanca, Salamanca, Spain., Martín-Izquierdo M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain., Hernández-Sánchez JM; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain., Rojas EA; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Hematology Department, University Hospital of Salamanca, Salamanca, Spain., Cardona-Benavides IJ; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Hematology Department, University Hospital of Salamanca, Salamanca, Spain., García-Sanz R; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Hematology Department, University Hospital of Salamanca, Salamanca, Spain.; Center for Biomedical Research in Network of Cancer (CIBERONC), Salamanca, Spain., Herrero AB; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Department of Medicine, University of Salamanca, Salamanca, Spain., Gutiérrez NC; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. normagu@usal.es.; Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain. normagu@usal.es.; Hematology Department, University Hospital of Salamanca, Salamanca, Spain. normagu@usal.es.; Center for Biomedical Research in Network of Cancer (CIBERONC), Salamanca, Spain. normagu@usal.es.
Publikováno v:
Experimental hematology & oncology [Exp Hematol Oncol] 2022 Mar 31; Vol. 11 (1), pp. 18. Date of Electronic Publication: 2022 Mar 31.
Autor:
Martín-Izquierdo M; Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain., Abáigar M; Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain., Hernández-Sánchez JM; Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain., Tamborero D; Hospital del Mar Medical Research Institute (IMIM), Barcelona and Karolinska Institutet, Stockholm., López-Cadenas F; University of Salamanca, IBSAL, Hematology, Hospital Clinico Universitario, Salamanca, Spain., Ramos F; Hematology, Hospital Universitario de León, Institute of Biomedicine (IBIOMED), Spain., Lumbreras E; Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain., Madinaveitia-Ochoa A; Hematology, Hospital Universitario Miguel Servet, Zaragoza, Spain., Megido M; Hematology, Hospital del Bierzo, Ponferrada, León, Spain., Labrador J; Hematology, Hospital Universitario de Burgos, Burgos, Spain., Sánchez-Real J; Hematology, Hospital Universitario de León, Institute of Biomedicine (IBIOMED), Spain., Olivier C; Hematology, Hospital General de Segovia, Segovia, Spain., Dávila J; Hematology, Hospital Nuestra Señora de Sónsoles, Ávila, Spain., Aguilar C; Hematology, Hospital Santa Bárbara, Soria, Spain., Rodríguez JN; Hematology, Hospital Juan Ramón Jiménez, Huelva, Spain., Martín-Nuñez G; Hematology, Hospital Virgen del Puerto, Plasencia, Spain., Santos-Mínguez S; Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain., Miguel-García C; Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain., Benito R; Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain., Díez-Campelo M; University of Salamanca, IBSAL, Hematology, Hospital Clínico Universitario, Salamanca, Spain., Hernández-Rivas JM; Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain.
Publikováno v:
Haematologica [Haematologica] 2021 Aug 01; Vol. 106 (8), pp. 2215-2223. Date of Electronic Publication: 2021 Aug 01.
Autor:
Quijada-Álamo M; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Pérez-Carretero C; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Sánchez M; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Rodríguez-Vicente AE; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Herrero AB; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Sánchez JM; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Martín-Izquierdo M; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Santos-Mínguez S; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Del Rey M; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., González T; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rubio-Martínez A; Department of Hematology, Hospital Miguel Servet, Zaragoza, Spain., García de Coca A; Department of Hematology, Hospital Clínico de Valladolid, Valladolid, Spain., Dávila-Valls J; Department of Hematology, Hospital Nuestra Señora de Sonsoles, Ávila, Spain., Hernández-Rivas JÁ; Department of Hematology, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain., Parker H; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Strefford JC; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Benito R; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Ordóñez JL; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Rivas JM; Cancer Research Center, University of Salamanca, IBSAL, IBMCC, CSIC, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Department of Medicine, University of Salamanca, Salamanca, Spain.
Publikováno v:
Clinical and translational medicine [Clin Transl Med] 2021 Feb; Vol. 11 (2), pp. e304.
Autor:
Vega-Garcia N; Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu 2, 08950 Esplugues de Llobregat, Barcelona, Spain.; Leukemia and other Pediatric Hemopathies, Developmental Tumors Biology Group, Institut de Recerca Hospital Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain., Benito R; IBSAL, IBMCC, CIC, Universidad de Salamanca-CSIC, 37008 Salamanca, Spain., Esperanza-Cebollada E; Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu 2, 08950 Esplugues de Llobregat, Barcelona, Spain.; Leukemia and other Pediatric Hemopathies, Developmental Tumors Biology Group, Institut de Recerca Hospital Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain., Llop M; Molecular Biology Unit, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain., Robledo C; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, 28222 Madrid, Spain., Vicente-Garcés C; Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu 2, 08950 Esplugues de Llobregat, Barcelona, Spain.; Leukemia and other Pediatric Hemopathies, Developmental Tumors Biology Group, Institut de Recerca Hospital Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain., Alonso J; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, 28222 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III (CB06/07/1009; CIBERER-ISCIII), 28029 Madrid, Spain., Barragán E; Molecular Biology Unit, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain., Fernández G; Molecular and Genetics Medicine Section, Hospital Sant Joan de Déu, Barcelona, Passeig Sant Joan de Déu 2, 08950 Esplugues de Llobregat, Barcelona, Spain.; Institut de Recerca Hospital Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain., Hernández-Sánchez JM; IBSAL, IBMCC, CIC, Universidad de Salamanca-CSIC, 37008 Salamanca, Spain., Martín-Izquierdo M; IBSAL, IBMCC, CIC, Universidad de Salamanca-CSIC, 37008 Salamanca, Spain., Maynou J; Molecular and Genetics Medicine Section, Hospital Sant Joan de Déu, Barcelona, Passeig Sant Joan de Déu 2, 08950 Esplugues de Llobregat, Barcelona, Spain.; Institut de Recerca Hospital Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain., Minguela A; Immunology Service, Virgen de la Arrixaca Clinic University Hospital, Biomedical Research Institute of Murcia (IMIB-Arrixaca), El Palmar, 30120 Murcia, Spain., Montaño A; IBSAL, IBMCC, CIC, Universidad de Salamanca-CSIC, 37008 Salamanca, Spain., Ortega M; Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), 08035 Barcelona, Spain., Torrebadell M; Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu 2, 08950 Esplugues de Llobregat, Barcelona, Spain.; Leukemia and other Pediatric Hemopathies, Developmental Tumors Biology Group, Institut de Recerca Hospital Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain., Cervera J; Hematology Service and Genetics Unit, Hospital de La Fe, 46026 Valencia, Spain., Sánchez J; Hematology Department, Hospital Reina Sofía, IMIBIC, University of Córdoba, 14004 Córdoba, Spain., Jiménez-Velasco A; Hematology and Hemotherapy Laboratory, Hospital Carlos Haya, 29010 Málaga, Spain., Riesco S; Pediatric Service, Hospital Universitario de Salamanca-IBSAL, 37007 Salamanca, Spain., Hernández-Rivas JM; Hematology Service, Hospital Universitario de Salamanca-IBSAL-USAL, 37007 Salamanca, Spain., Lassaletta Á; Department of Pediatric Hematology & Oncology, Hospital Universitario Niño Jesús, 28009 Madrid, Spain., Fernández JM; Pediatric Oncohematology Unit, Hospital de La Fe, 46026 Valencia, Spain., Rives S; Leukemia and other Pediatric Hemopathies, Developmental Tumors Biology Group, Institut de Recerca Hospital Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Paediatric Haematology and Oncology Department, Hospital Sant Joan de Déu Barcelona, University of Barcelona, 08950 Barcelona, Spain., Dapena JL; Leukemia and other Pediatric Hemopathies, Developmental Tumors Biology Group, Institut de Recerca Hospital Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain.; Paediatric Haematology and Oncology Department, Hospital Sant Joan de Déu Barcelona, University of Barcelona, 08950 Barcelona, Spain., Ramírez M; Hematology Laboratory, Hospital Niño Jesús, 28009 Madrid, Spain., Camós M; Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu 2, 08950 Esplugues de Llobregat, Barcelona, Spain.; Leukemia and other Pediatric Hemopathies, Developmental Tumors Biology Group, Institut de Recerca Hospital Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain., On Behalf Of The Group Of Leukemia Of The Spanish Society Of Pediatric Hematology And Oncology Sehop
Publikováno v:
Journal of personalized medicine [J Pers Med] 2020 Nov 26; Vol. 10 (4). Date of Electronic Publication: 2020 Nov 26.
Autor:
Hernández-Sánchez JM; Department of Hematology, Hospital Universitario Salamanca , Salamanca, Spain.; IBSAL,IBMCC-Cancer Research Center, University of Salamanca , Salamanca, Spain., Bastida JM; Department of Hematology, Hospital Universitario Salamanca , Salamanca, Spain.; IBSAL,IBMCC-Cancer Research Center, University of Salamanca , Salamanca, Spain., Alonso-López D; Bioinformatics Unit, Cancer Research Center (CSIC-USAL) , Salamanca, Spain., Benito R; Department of Hematology, Hospital Universitario Salamanca , Salamanca, Spain.; IBSAL,IBMCC-Cancer Research Center, University of Salamanca , Salamanca, Spain., González-Porras JR; Department of Hematology, Hospital Universitario Salamanca , Salamanca, Spain.; IBSAL,IBMCC-Cancer Research Center, University of Salamanca , Salamanca, Spain., De Las Rivas J; Bioinformatics Unit, Cancer Research Center (CSIC-USAL) , Salamanca, Spain., Hernández Rivas JM; Department of Hematology, Hospital Universitario Salamanca , Salamanca, Spain.; IBSAL,IBMCC-Cancer Research Center, University of Salamanca , Salamanca, Spain., Rodríguez-Vicente AE; Department of Hematology, Hospital Universitario Salamanca , Salamanca, Spain.; IBSAL,IBMCC-Cancer Research Center, University of Salamanca , Salamanca, Spain.
Publikováno v:
Platelets [Platelets] 2020 Nov 16; Vol. 31 (8), pp. 993-1000. Date of Electronic Publication: 2019 Dec 14.
Autor:
Pérez-Carretero C; Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Hernández-Sánchez M; Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA., González T; Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Quijada-Álamo M; Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Martín-Izquierdo M; Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Hernández-Sánchez JM; Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Vidal MJ; Servicio de Hematología, Hospital Universitario, León, Spain., de Coca AG; Servicio de Hematología, Hospital Clínico, Valladolid, Spain., Aguilar C; Servicio de Hematología, Complejo Hospitalario de Soria, Soria, Spain., Vargas-Pabón M; Servicio de Hematología, Hospital Jarrio, Asturias, Spain., Alonso S; Servicio de Hematología, Hospital Universitario Central de Asturias, Oviedo, Spain., Sierra M; Servicio de Hematología, Hospital Virgen de la Concha, Zamora, Spain., Rubio-Martínez A; Servicio de Hematología, Hospital Miguel Servet, Zaragoza, Spain., Dávila J; Servicio de Hematología, Hospital Nuestra Señora de Sonsoles, Ávila, Spain., Díaz-Valdés JR; Servicio de Hematología, Hospital General de Segovia, Segovia, Spain., Queizán JA; Servicio de Hematología, Hospital General de Segovia, Segovia, Spain., Hernández-Rivas JÁ; Servicio de Hematología, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain., Benito R; Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Rodríguez-Vicente AE; Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Hernández-Rivas JM; Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.
Publikováno v:
International journal of cancer [Int J Cancer] 2020 Nov 15; Vol. 147 (10), pp. 2780-2792. Date of Electronic Publication: 2020 Sep 04.
Autor:
Quijada-Álamo M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Sánchez M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA., Alonso-Pérez V; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rodríguez-Vicente AE; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., García-Tuñón I; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Martín-Izquierdo M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Sánchez JM; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Herrero AB; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Bastida JM; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., San Segundo L; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Gruber M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA.; CeMM Research Center for Molecular Medicine, Vienna, Austria.; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., García JL; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA., Ten Hacken E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA., Benito R; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Ordóñez JL; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain. jlog@usal.es.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain. jlog@usal.es., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA. cwu@partners.org.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA. cwu@partners.org., Hernández-Rivas JM; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain. jmhr@usal.es.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain. jmhr@usal.es.; Department of Medicine, University of Salamanca, Salamanca, Spain. jmhr@usal.es.
Publikováno v:
Leukemia [Leukemia] 2020 Jun; Vol. 34 (6), pp. 1599-1612. Date of Electronic Publication: 2020 Jan 23.